KIAA2013: A Potential Drug Target for Various Diseases (G90231)

Target Name: KIAA2013

NCBI ID: G90231

KIAA2013

Other Name(s): K2013_HUMAN | Uncharacterized protein KIAA2013 | RP5-1077B9.1

KIAA2013: A Potential Drug Target for Various Diseases

KIAA2013 (K2013_HUMAN) is a protein that is expressed in various tissues of the human body, including the brain, heart, liver, and kidney. It is a member of the Kallikrein family of proteins, which are involved in the regulation of cell signaling pathways.

KIAA2013 has been identified as a potential drug target due to its involvement in several cellular processes that are associated with various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the key functions of KIAA2013 is its role in the regulation of angiogenesis, which is the process by which new blood vessels are formed to supply oxygen and nutrients to tissues. In cancer, KIAA2013 has been shown to promote the growth and survival of cancer cells by inhibiting the formation of new blood vessels.

Another function of KIAA2013 is its role in cell signaling pathways. It has been shown to play a role in the regulation of several signaling pathways that are involved in cell growth, differentiation, and survival.

KIAA2013 is also involved in the regulation of inflammation, which is a critical part of the immune system. In diseases such as autoimmune disorders, KIAA2013 has been shown to contribute to the development and progression of these conditions by regulating the activity of immune cells.

In addition to its role in cellular signaling pathways and inflammation, KIAA2013 is also involved in the regulation of the blood-brain barrier. The blood-brain barrier is a critical barrier that helps to protect the brain from harmful substances and substances that should not be allowed to enter the brain. KIAA2013 has been shown to play a role in the regulation of this barrier by allowing certain substances to enter the brain while inhibiting the entry of others.

Given its involvement in several cellular processes that are associated with various diseases, KIAA2013 has been identified as a potential drug target. Researchers are currently working to develop small molecules that can inhibit the activity of KIAA2013 and use it as a drug target for various diseases.

In conclusion, KIAA2013 is a protein that is involved in several cellular processes that are associated with various diseases. Its potential as a drug target makes it an attractive target for researchers to investigate and develop new treatments for a variety of diseases. Further studies are needed to fully understand the role of KIAA2013 in cellular processes and its potential as a drug target.

Protein Name: KIAA2013

The "KIAA2013 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KIAA2013 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets